Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review.
A double-blind, placebo-controlled study by Kapoor et al., in 2016 found 100 patients with coronary artery disease given 500 mg arjuna twice daily in addition to conventional therapy had significant decreases in hyperlipidemia and in multiple inflammatory cytokines including IL-6 and TNF-alpha.
References;
INGREDIENTS WITH THIS RESEARCH
Let’s keep in touch
Don’t worry we only send updates monthly on offers, product changes, and new opportunities for you.
"*" indicates required fields